Natixis’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50.7M | Sell |
233,196
-112,180
| -32% | -$24.9M | 0.18% | 78 |
|
|
2025
Q4 | $78.9M | Buy |
345,376
+122,238
| +55% | +$27.8M | 0.28% | 51 |
|
|
2025
Q3 | $51.7M | Sell |
223,138
-12,502
| -5% | -$2.55M | 0.24% | 65 |
|
|
2025
Q2 | $43.7M | Buy |
235,640
+3,109
| +1% | +$578K | 0.19% | 74 |
|
|
2025
Q1 | $48.2M | Buy |
232,531
+156,918
| +208% | +$30.5M | 0.26% | 57 |
|
|
2024
Q4 | $13.4M | Sell |
75,613
-313,257
| -81% | -$57.6M | 0.08% | 177 |
|
|
2024
Q3 | $76.8M | Sell |
388,870
-255,917
| -40% | -$47.8M | 0.43% | 40 |
|
|
2024
Q2 | $111M | Buy |
644,787
+476,883
| +284% | +$79M | 0.63% | 30 |
|
|
2024
Q1 | $30.6M | Sell |
167,904
-209,342
| -55% | -$36.1M | 0.16% | 108 |
|
|
2023
Q4 | $58.5M | Buy |
377,246
+4,301
| +1% | +$627K | 0.42% | 46 |
|
|
2023
Q3 | $55.6M | Sell |
372,945
-124,215
| -25% | -$18.2M | 0.43% | 48 |
|
|
2023
Q2 | $67M | Buy |
497,160
+99,691
| +25% | +$14.6M | 0.54% | 31 |
|
|
2023
Q1 | $63.3M | Sell |
397,469
-203,222
| -34% | -$31.1M | 0.57% | 30 |
|
|
2022
Q4 | $97.1M | Buy |
600,691
+246,906
| +70% | +$37.9M | 0.54% | 47 |
|
|
2022
Q3 | $47.6M | Sell |
353,785
-21,187
| -6% | -$3.04M | 0.22% | 76 |
|
|
2022
Q2 | $57.4M | Buy |
374,972
+199,803
| +114% | +$30.5M | 0.21% | 59 |
|
|
2022
Q1 | $28.4M | Buy |
175,169
+43,151
| +33% | +$6.27M | 0.1% | 197 |
|
|
2021
Q4 | $17.7M | Sell |
132,018
-64,874
| -33% | -$7.66M | 0.06% | 269 |
|
|
2021
Q3 | $21.2M | Sell |
196,892
-463,295
| -70% | -$52.9M | 0.07% | 224 |
|
|
2021
Q2 | $74.4M | Buy |
660,187
+648,217
| +5,415% | +$73M | 0.32% | 75 |
|
|
2021
Q1 | $1.29M | Sell |
11,970
-1,245,414
| -99% | -$133M | ﹤0.01% | 790 |
|
|
2020
Q4 | $133M | Buy |
1,257,384
+430,416
| +52% | +$41.4M | 0.48% | 41 |
|
|
2020
Q3 | $72.4M | Sell |
826,968
-541,177
| -40% | -$50.9M | 0.53% | 46 |
|
|
2020
Q2 | $134M | Sell |
1,368,145
-504,589
| -27% | -$44.4M | 1.04% | 16 |
|
|
2020
Q1 | $143M | Buy |
1,872,734
+296,731
| +19% | +$25.3M | 1.12% | 14 |
|
|
2019
Q4 | $140M | Buy |
1,576,003
+1,261,124
| +401% | +$105M | 0.86% | 16 |
|
|
2019
Q3 | $23.8M | Sell |
314,879
-1,452,741
| -82% | -$99.6M | 0.15% | 140 |
|
|
2019
Q2 | $129M | Buy |
1,767,620
+1,141,797
| +182% | +$89.7M | 0.99% | 19 |
|
|
2019
Q1 | $50M | Buy |
625,823
+538,860
| +620% | +$44.1M | 0.31% | 78 |
|
|
2018
Q4 | $7.92M | Sell |
86,963
-2,019,377
| -96% | -$178M | 0.07% | 253 |
|
|
2018
Q3 | $199M | Buy |
2,106,340
+1,528,976
| +265% | +$145M | 1.15% | 13 |
|
|
2018
Q2 | $53M | Buy |
577,364
+306,883
| +113% | +$30M | 0.28% | 92 |
|
|
2018
Q1 | $25.3M | Sell |
270,481
-433,905
| -62% | -$47.7M | 0.16% | 147 |
|
|
2017
Q4 | $68.1M | Buy |
704,386
+408,654
| +138% | +$38.5M | 0.52% | 49 |
|
|
2017
Q3 | $26.3M | Sell |
295,732
-46,609
| -14% | -$3.55M | 0.24% | 105 |
|
|
2017
Q2 | $24.8M | Buy |
+342,341
| New | +$23M | 0.28% | 89 |
|
|
2017
Q1 | – | Sell |
-229,630
| Closed | -$14.4M | – | 928 |
|
|
2016
Q4 | $14.4M | Buy |
+229,630
| New | +$14M | 0.15% | 161 |
|
|
2016
Q3 | – | Sell |
-66,889
| Closed | -$4.14M | – | 519 |
|
|
2016
Q2 | $4.14M | Buy |
+66,889
| New | +$4.08M | 0.08% | 188 |
|
|
2016
Q1 | – | Sell |
-9,336
| Closed | -$553K | – | 303 |
|
|
2015
Q4 | $553K | Buy |
9,336
+3,526
| +61% | +$203K | 0.01% | 224 |
|
|
2015
Q3 | $316K | Sell |
5,810
-14,331
| -71% | -$933K | 0.01% | 234 |
|
|
2015
Q2 | $1.35M | Sell |
20,141
-26,598
| -57% | -$1.74M | 0.02% | 185 |
|
|
2015
Q1 | $2.74M | Sell |
46,739
-445,037
| -90% | -$26.9M | 0.04% | 165 |
|
|
2014
Q4 | $32.2M | Buy |
491,776
+453,218
| +1,175% | +$28.6M | 0.44% | 42 |
|
|
2014
Q3 | $2.23M | Sell |
38,558
-90,685
| -70% | -$5.03M | 0.03% | 192 |
|
|
2014
Q2 | $7.29M | Sell |
129,243
-292,788
| -69% | -$15.4M | 0.09% | 154 |
|
|
2014
Q1 | $21.7M | Sell |
422,031
-1,181
| -0.3% | -$59.7K | 0.28% | 83 |
|
|
2013
Q4 | $22.4M | Sell |
423,212
-63,034
| -13% | -$3.1M | 0.19% | 110 |
|
|
2013
Q3 | $21.7M | Buy |
486,246
+121,862
| +33% | +$5.4M | 0.23% | 102 |
|
|
2013
Q2 | $15.1M | Buy |
+364,384
| New | +$15.9M | 0.22% | 103 |
|
Other funds holding ABBV
VCM
VPM
Natixis's ABBV Position: Q1 2026 in Review
Natixis reduced its AbbVie (ABBV) stake by 32% in Q1 2026, selling an estimated $24.9M and leaving 233,196 shares worth $50.7M. The position accounts for 0.18% of the portfolio, ranked #78.
Natixis first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $199M in Q3 2018. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Natixis held 233,196 shares of AbbVie worth $50.7M as of Q1 2026.
- Natixis sold 112,180 AbbVie shares in Q1 2026, an estimated $24.9M.
- AbbVie made up 0.18% of Natixis's portfolio in Q1 2026, its #78 holding.
- Natixis first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
- Natixis's AbbVie position peaked at $199M in Q3 2018.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.